Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03617926 · ClinicalTrials.gov registry record · NA
A Clinical Trial to Evaluate Efficacy and Safety of a Water-soluble Head Lice Product.
A NA study of Head Lice and Pediculosis Capitis, sponsored by Oystershell.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 2
- Study locations
NCT03617926 is a NA study of Head Lice and Pediculosis Capitis that has completed, run by Oystershell. The registered enrollment target is 70 participants, below the 103-participant average among 5 other Head Lice trials with a reported enrollment target (32% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT03617926, a NA study of Head Lice and Pediculosis Capitis, has completed, sponsored by Oystershell.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 2
- Study locations
Study Summary
The present study is set-up to compare in vivo clinical performance and safety of the test product versus an in the US commercially available, pyrethrum-based product (RID® shampoo).
Conditions Studied
Interventions
- DEVICE X92001666
- OTHER RID shampoo
Study Locations (2)
Florida
- South Fla. Family Health & Research Ctr.LLC - Miami
- Lice Source Services, Inc. - Plantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2018-03-07 |
| Est. Completion | 2018-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03617926
The ClinicalTrials.gov registry entry for NCT03617926 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 103-participant average among 5 other Head Lice trials with a reported enrollment target (32% lower). The listed sponsor is Oystershell, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Head Lice appearing as the primary indexed condition, and to 2 interventions - of which X92001666 is the first listed.
NCT03617926 reports 2 study locations spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT03617926 about?
NCT03617926 is a clinical study titled "A Clinical Trial to Evaluate Efficacy and Safety of a Water-soluble Head Lice Product.". The present study is set-up to compare in vivo clinical performance and safety of the test product versus an in the US commercially available, pyrethrum-based product (RID® shampoo).
What is the current status of trial NCT03617926?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2018-03-07. Estimated completion is 2018-06-30.
What conditions does trial NCT03617926 study?
This clinical trial studies the following conditions: Head Lice, Pediculosis Capitis.
What interventions are being tested in trial NCT03617926?
The interventions under investigation include: X92001666 (DEVICE), RID shampoo (OTHER).
Who is sponsoring clinical trial NCT03617926?
This trial is sponsored by Oystershell, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03617926 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head Lice
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Efficacy of Head-lice Treatments Elimax Green Lotion and Walgreens Lice Killing Shampoo
RECRUITING · NA
-
Safety and Efficacy Study to Compare a 4% Dimethicone Foam and Nix Cream Rinse (1% Permethrin) in the Control of Head Lice
COMPLETED · NA
-
Pediatric Head Lice Study Product Comparison
COMPLETED · Phase 2
-
Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects
COMPLETED · Phase 2
-
A Pilot Dose Ranging Study of Spinosad Creme Rinse
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.